Quantcast

Latest Nycomed Stories

2010-02-04 07:01:00

BETHESDA, Md., Feb. 4 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI) today announced that it will host a Research & Development Day for the investment community on Wednesday, February 10, 2010 from 8:00 AM - 11:00 AM ET at the Yale Club in New York City.

2010-02-04 07:00:00

BETHESDA, Md., Feb. 4 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI) today announced that the Company will participate in the 12th Annual BIO CEO & Investor Conference, to be held February 8th - 9th in New York City.

2010-01-19 07:00:00

CUPERTINO, Calif., Jan. 19 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX) announced today that it has begun dosing patients in its U.S. pivotal Phase III clinical trial to evaluate POSIDUR(TM) (SABER(TM)-Bupivacaine), an investigational drug, for the treatment of post-surgical pain.

2010-01-07 07:00:00

BETHESDA, Md., Jan. 7 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI) today announced that it will participate in the 28th Annual J.P. Morgan Healthcare Conference, to be held January 11th - 14th in San Francisco.

2009-12-17 07:30:00

CUPERTINO, Calif., Dec. 17 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX) announced today positive results from a 60 patient Phase IIb clinical trial of POSIDUR(TM), a proprietary product under development for the treatment of post-surgical pain.

2009-09-09 02:00:00

LISBON, Portugal, September 9 /PRNewswire/ -- - Choosing a More Appropriate Route of Administration for Fast Acting Pain Relief Could be the key to Improvement The first results of the first European survey of cancer patients' experience of breakthrough pain[1] were presented today at the 6th congress of the European Federation of Chapters of the International Association for the Study of Pain (EFIC). (Logo: http://www.newscom.com/cgi-bin/prnh/20090909/358726 ) Previous...

2009-07-20 06:00:00

ZURICH, July 20 /PRNewswire/ -- Nycomed today announced the submission of a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for Daxas(R) as a once-daily oral treatment for patients with symptomatic COPD.

2009-06-18 06:00:00

BETHESDA, Md., June 18 /PRNewswire-FirstCall/ -- Micromet, Inc.


Word of the Day
plim
  • To swell, as grain or wood with water.
The word 'plim' is probably a variant of the word 'plum'.
Related